BioCentury
ARTICLE | Clinical News

Zavesca miglustat regulatory update

March 29, 2010 7:00 AM UTC

Health Canada approved Actelion's Zavesca miglustat to treat Niemann-Pick type C disease. Zavesca is also approved in Australia, Brazil, Russia, South Korea and the EU in the indication. The oral N-bu...